FEUIX
Price
$27.54
Change
+$0.20 (+0.73%)
Updated
Jun 23 closing price
Net Assets
144.94M
RNPHX
Price
$67.88
Change
+$0.96 (+1.43%)
Updated
Jun 24 closing price
Net Assets
149.31B
Interact to see
Advertisement

FEUIX vs RNPHX

Header iconFEUIX vs RNPHX Comparison
Open Charts FEUIX vs RNPHXBanner chart's image
Fidelity Advisor Glbl Capital Apprec I
Price$27.54
Change+$0.20 (+0.73%)
VolumeN/A
Net Assets144.94M
American Funds New Perspective R5E
Price$67.88
Change+$0.96 (+1.43%)
VolumeN/A
Net Assets149.31B
FEUIX vs RNPHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FEUIX vs. RNPHX commentary
Jun 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FEUIX is a Buy and RNPHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPHX has more cash in the bank: 149B vs. FEUIX (145M). RNPHX pays higher dividends than FEUIX: RNPHX (0.70) vs FEUIX (0.00). FEUIX was incepted earlier than RNPHX: FEUIX (27 years) vs RNPHX (10 years). FEUIX (1.00) is less costly to investors than RNPHX (0.56). FEUIX is a more actively managed with annual turnover of: 47.00 vs. RNPHX (24.00). FEUIX has a lower initial minimum investment than RNPHX: FEUIX (0) vs RNPHX (250). RNPHX annual gain was more profitable for investors over the last year : 8.06 vs. FEUIX (0.37). FEUIX return over 5 years is better than : 51.80 vs. RNPHX (44.90).
FEUIXRNPHXFEUIX / RNPHX
Total Expense Ratio1.000.56179%
Annual Report Gross Expense Ratio1.000.56179%
Fund Existence27 years10 years-
Gain YTD1.4477.89418%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets145M149B0%
Annual Yield % from dividends0.000.70-
Returns for 1 year0.378.065%
Returns for 3 years50.3936.18139%
Returns for 5 years51.8044.90115%
Returns for 10 years53.92N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NKTR9.541.03
+12.10%
Nektar Therapeutics
HBNC15.090.49
+3.36%
Horizon Bancorp
SNN29.170.34
+1.18%
Smith & Nephew plc
BANC13.910.11
+0.80%
Banc of California
TOVX0.43N/A
-0.76%
Theriva Biologics Inc